|
ARD
MCID: RFS001
|
Refsum Disease malady |
|
9 drugs, 41 genes, 4 tissues, 423 related diseases, 4 phenotypes, 31 articles, clinical trials, genetic tests.
|
|
|
Sources: 30NIH Rare Diseases, 31NINDS, 17Genetics Home Reference, 15GeneReviews, 33OMIM, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Refsum disease is an inherited condition that causes vision loss, loss of smell (anosmia), and a variety of other signs and symptoms. The vision loss associated with Refsum disease is caused by an eye disorder called retinitis pigmentosa. Other features can include bone abnormalities of the hands and feet; progressive muscle weakness and wasting; poor balance and coordination (ataxia); hearing loss; arrhythmias and heart abnormalities; and dry, scaly skin (ichthyosis). Refsum disease can result from mutations in the PHYH gene or the PEX7 gene and is inherited in an autosomal recessive pattern.30
MalaCards: Refsum Disease, also known as heredopathia atactica polyneuritiformis, is related to infantile refsum disease and refsum disease, infantile form. An important gene associated with Refsum Disease is PHYH (phytanoyl-CoA 2-hydroxylase), and among its related pathways are ABCA transporters in lipid homeostasis and Valine, leucine and isoleucine degradation. The drugs acetylcysteine and nitrous oxide and the compounds 2-hydroxyphytanoyl-coa and lignoceric acid have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and liver, and related mouse phenotypes are muscle and liver/biliary system. NINDS: Adult Refsum disease (ARD) is a rare genetic disease that causes weakness or numbness of the hands and feet (peripheral neuropathy). 31 Genetics Home Reference: Refsum disease is an inherited condition that causes vision loss, absence of the sense of smell (anosmia), and a variety of other signs and symptoms.17 Wikipedia: Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis,...44 more... OMIM: 266500 GeneReviews summary for refsum |
|
Sources: 43UMLS, 6Disease Ontology, 7diseasecard, 15GeneReviews, 30NIH Rare Diseases, 17Genetics Home Reference, 31NINDS, 8DISEASES, 33OMIM, 32Novoseek , 16GeneTests, 27NCIt, 24MeSH, 19ICD9CM, 40SNOMED-CT See all sources |
Aliases & Descriptions:
|
|
Sources: 33OMIM See all sources |
Clinical features from OMIM: 266500
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials, 43UMLS, 28NDF-RT See all sources |
Approved drugs:Search CenterWatch for refsum disease Drug clinical trials:Search ClinicalTrials for refsum disease Search NIH Clinical Center for refsum disease Search CenterWatch for refsum disease Inferred drug relations via UMLS/NDF-RT:43 28 acetylcysteine, albumin,human, albumin,human inj [va product], epoprostenol, epoprostenol sodium, methylprednisolone, methylprednisolone acetate, methylprednisolone sodium succinate, nitrous oxide |
|
Sources: 16GeneTests See all sources |
|
Sources: 22MalaCards See all sources |
MalaCards organs/tissues related to refsum disease:22Brain, Heart, Liver, Skin
|
|
Sources: 25MGI See all sources |
MGI Mouse Phenotypes related to refsum disease:25
|
|
Sources: 35PubMed See all sources |
Articles related to refsum disease:(show all 31)
|
|
Sources: 1BioGPS See all sources |
![]() |
|
Sources: 38Reactome, 20KEGG See all sources |
Pathways related to refsum disease according to GeneDecks:
|
|
Sources: 32Novoseek , 18HMDB, 9DrugBank See all sources |
Compounds related to refsum disease according to GeneDecks:(show all 39)
|
|
Sources: 12Gene Ontology See all sources |
Cellular components related to refsum disease according to GeneDecks:
Biological processes related to refsum disease according to GeneDecks:(show all 22)
Molecular functions related to refsum disease according to GeneDecks:(show all 10)
|
